Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models. Zhu X, Qi B, Ren Z, Cong L, et al. Invest Ophthalmol Vis Sci 2025;66:48.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu X, Qi B, Ren Z, Cong L, et al. Targeted Neuroprotection of Retinal Ganglion Cells Via AAV2-hSyn-NGF Gene Therapy in Glaucoma Models. Invest Ophthalmol Vis Sci 2025;66:48.
PMID: 40244606